Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease

NCT02336646 is registered in ClinicalTrials.gov with Taiwan Bio Therapeutics Inc. as lead sponsor.

NCT NCT02336646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02336646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease
Lead sponsor
Taiwan Bio Therapeutics Inc.
Phase
Phase 1
Overall status
Completed
Start date
May 1, 2015
Completion date
December 20, 2018
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia